Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t there or believe that others are reading or controlling their minds.

Research indicates that the global schizophrenia market was worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during the period 2011-2014. The therapeutic market for schizophrenia is expected to decline form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014, the situation is set to improve. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore, a low treatment seeking rate and low patient compliance rate are likely to act as a barrier to market growth.

The Schizophrenia drug therapy market research report provides insight into the pipeline status of schizophrenia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the schizophrenia drugs & therapy market.

TITLE	Actions
Global Schizophrenia Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in May 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Sch...
Global Schizophrenia Therapeutic Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in May 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Therapeutic market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of t...
Global Schizophrenia Treatments Market Research Report 2023 Published in Apr 2023 \| US $ 2900 Onwards \| By QYResearch Group Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Highlights The global Schizophrenia Treatments market was valued at US$ 10010 million in 2022 and is anticipated to reach U...
Global Schizophrenia Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in Mar 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the...
Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028 Published in Feb 2023 \| US $ 3160 Onwards \| By Multimarket Insight Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and...
Global Long-Acting Schizophrenia Drug Market Research Report 2023 Published in Feb 2023 \| US $ 2900 Onwards \| By QYResearch Group Second-generation antipsychotics are serotonin-dopamine antagonists and are also known as atypical antipsychotics. Highlights The global Long-Acting Schizophrenia Drug market was valued at US$ million in 2022 and is anticipated to reach...
Global Schizophrenia Related Peptide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 Published in Feb 2023 \| US $ 3480 Onwards \| By Global Info Research According to our (Global Info Research) latest study, the global Schizophrenia Related Peptide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influe...
Global Schizophrenia Related Peptide Market Research Report 2023 Published in Jan 2023 \| US $ 2900 Onwards \| By QYResearch Group Highlights The global Schizophrenia Related Peptide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Nether...
Schizophrenia Related Peptide Market, Global Outlook and Forecast 2023-2029 Published in Jan 2023 \| US $ 3250 Onwards \| By Market Monitor Global This report aims to provide a comprehensive presentation of the global market for Schizophrenia Related Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situat...
Global Schizophrenia Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Nov 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Therapeutic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides st...
Global Schizophrenia Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Nov 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Treatment market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides stra...
Global Schizophrenia Treatments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Nov 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access...
Global Schizophrenia Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Oct 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategi...
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Published in Sep 2022 \| US $ 2500 Onwards \| By Global Markets Direct Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Drugs In ...
Global Schizophrenia Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Sep 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access...
Global Schizophrenia Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Sep 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is...
Global Long-Acting Schizophrenia Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028 Published in Sep 2022 \| US $ 3480 Onwards \| By Global Info Research Second-generation antipsychotics are serotonin-dopamine antagonists and are also known as atypical antipsychotics. The Long-Acting Schizophrenia Drug market report provides a detailed analysis of global market size, regional and country-level...
Global Long-Acting Schizophrenia Drug Market Research Report 2022 Published in Sep 2022 \| US $ 2900 Onwards \| By QYResearch Group This report aims to provide a comprehensive presentation of the global market for Long-Acting Schizophrenia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situa...
2022-2029 Global Schizophrenia Treatment Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography) Published in Aug 2022 \| US $ 2980 Onwards \| By Maia Research The Schizophrenia Treatment market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Schizophrenia T...
2022-2029 Global Schizophrenia Drugs Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography) Published in Jul 2022 \| US $ 2980 Onwards \| By Maia Research The Schizophrenia Drugs market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Schizophrenia Drugs...

We are on:

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

TITLE	Actions
Global Schizophrenia Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in May 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Sch...
Global Schizophrenia Therapeutic Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in May 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Therapeutic market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of t...
Global Schizophrenia Treatments Market Research Report 2023 Published in Apr 2023 \| US $ 2900 Onwards \| By QYResearch Group Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Highlights The global Schizophrenia Treatments market was valued at US$ 10010 million in 2022 and is anticipated to reach U...
Global Schizophrenia Treatment Market Insights: Impact of COVID-19 and Future Expectations to 2028 Published in Mar 2023 \| US $ 3260 Onwards \| By Maia Research The Schizophrenia Treatment market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the...
Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028 Published in Feb 2023 \| US $ 3160 Onwards \| By Multimarket Insight Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and...
Global Long-Acting Schizophrenia Drug Market Research Report 2023 Published in Feb 2023 \| US $ 2900 Onwards \| By QYResearch Group Second-generation antipsychotics are serotonin-dopamine antagonists and are also known as atypical antipsychotics. Highlights The global Long-Acting Schizophrenia Drug market was valued at US$ million in 2022 and is anticipated to reach...
Global Schizophrenia Related Peptide Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 Published in Feb 2023 \| US $ 3480 Onwards \| By Global Info Research According to our (Global Info Research) latest study, the global Schizophrenia Related Peptide market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influe...
Global Schizophrenia Related Peptide Market Research Report 2023 Published in Jan 2023 \| US $ 2900 Onwards \| By QYResearch Group Highlights The global Schizophrenia Related Peptide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Nether...
Schizophrenia Related Peptide Market, Global Outlook and Forecast 2023-2029 Published in Jan 2023 \| US $ 3250 Onwards \| By Market Monitor Global This report aims to provide a comprehensive presentation of the global market for Schizophrenia Related Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situat...
Global Schizophrenia Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Nov 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Therapeutic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides st...
Global Schizophrenia Treatment Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Nov 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Treatment market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides stra...
Global Schizophrenia Treatments Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Nov 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access...
Global Schizophrenia Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends Published in Oct 2022 \| US $ 3450 Onwards \| By Maia Research The report focuses on the Schizophrenia Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategi...
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Published in Sep 2022 \| US $ 2500 Onwards \| By Global Markets Direct Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Drugs In ...
Global Schizophrenia Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Sep 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, revenue and gross margin. Major players headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access...
Global Schizophrenia Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028 Published in Sep 2022 \| US $ 5600 Onwards \| By QYResearch Group Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is...
Global Long-Acting Schizophrenia Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028 Published in Sep 2022 \| US $ 3480 Onwards \| By Global Info Research Second-generation antipsychotics are serotonin-dopamine antagonists and are also known as atypical antipsychotics. The Long-Acting Schizophrenia Drug market report provides a detailed analysis of global market size, regional and country-level...
Global Long-Acting Schizophrenia Drug Market Research Report 2022 Published in Sep 2022 \| US $ 2900 Onwards \| By QYResearch Group This report aims to provide a comprehensive presentation of the global market for Long-Acting Schizophrenia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situa...
2022-2029 Global Schizophrenia Treatment Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography) Published in Aug 2022 \| US $ 2980 Onwards \| By Maia Research The Schizophrenia Treatment market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Schizophrenia T...
2022-2029 Global Schizophrenia Drugs Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography) Published in Jul 2022 \| US $ 2980 Onwards \| By Maia Research The Schizophrenia Drugs market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Schizophrenia Drugs...